Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Amgen
A retrospective observational study reviewing historical survival data (hematological remission and survival) for adult patients who have either relapsed or refractory B-precursor acute lymphoblastic leukemia. Data are aggregated across multiple countries and study sites in the EU and US
Age
15–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
adult patients with relapsed / refractory B-precursor acute lymphoblastic leukemia
age 15 or older at time of de novo (initial) diagnosis of acute lymphoblastic leukemia
initial diagnosis of acute lymphoblastic leukemia in the year 1990 or later
No CNS involvement at relapse
No isolated extramedullary relapse
Clareo Health | Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia
